Medical Marijuana Costs in the US: What Patients Should Know
Medical Marijuana Costs in the US: What Patients Should Know
Medical Cannabis
The Hidden Science of Cannabis: Minor Cannabinoids, Genetic Discoveries, and the Future of the Plant
Cannabis science is entering a new era. Researchers are uncovering the power of minor cannabinoids, mapping the cannabis genome, and producing cannabinoids through synthetic biology. These discoveries reveal the plant as a vast pharmacological library with enormous potential for medicine.
The Science Behind Cannabis Seeds and Why Genetics Matter More Than Ever
Cannabis seeds contain the genetic blueprint that determines plant structure, cannabinoid levels, terpene profiles, and resilience. As cultivation evolves globally, understanding genetics and choosing stable seed sources has become essential for growers seeking consistent, high-quality harvests.
Prof. Dedi Meiri and the Molecular Future of Cannabis
Technion Israel Institute of Technology, Prof. Dedi Meiri is redefining cannabis science through molecular research. From cancer pathways to the endocannabinoid system, his lab maps how specific cannabinoid profiles interact with disease, bringing precision, data, and clarity to medical cannabis.
What Are RSO Capsules? A Clear Guide to Rick Simpson Oil
RSO capsules offer a discreet, full-spectrum way to experience Rick Simpson Oil without syringes or taste. This guide explains what RSO capsules are, how they differ from oils and edibles, how dosing works, and why some people prefer them.
Rescheduling Cannabis: Progress, Power, and the Question of Who Benefits Industry Insiders Weigh in
The U.S. decision to reschedule cannabis to Schedule III signals federal recognition of medical value. Industry voices examine 280E tax relief, research access, patient impact, and the unresolved limits of reform.
Governor Hochul Signs Landmark Bill Modernizing New York’s Medical Cannabis Program
Governor Hochul has signed Senate Bill 2025-S3294A, delivering the most significant update to New York’s medical cannabis program since 2016. The law expands patient access, adds reciprocity, clarifies rights, and permits home cultivation for certified adults.
Canify AG: Precision, Compliance, and the Future of Medical Cannabis in Germany
Canify AG is redefining Germany’s medical cannabis industry through pharmaceutical precision and plant-based innovation. Led by CEO Sascha Mielcarek, the company blends global sourcing with strict compliance to shape Europe’s next era of medical care.
Four 20 Pharma CEO Torsten Greif: Redefining Medical Cannabis in Germany and Beyond
Four 20 Pharma CEO Torsten Greif is redefining medical cannabis in Germany — from EU-GMP supply chains and certified vapes to a historic soccer sponsorship that put plant medicine on the global stage.
Remexian Pharma, Germany, and the New Rules of the Medical Game
At Expopharm Düsseldorf, Honeysuckle spoke with Remexian Pharma leaders Stefan Adomeit and Francesco Baganz about Germany’s rapidly evolving medical market—where patient demand, shrinking margins, and cross-border consolidation are reshaping the future.
What Happens to Cannabis Culture If the U.S. Goes Full Pharma?
If the U.S. cannabis industry shifts into a pharmaceutical model, what happens to the culture built on community, creativity, and flavor? We explore how pharma could reshape weed—and why preserving the experience matters more than ever.
Expopharm 2025: Cannabis and Plant-Based Therapies Enter Europe’s Pharma Mainstream
At Expopharm 2025 in Düsseldorf, Europe’s largest pharma trade fair, cannabis was given a dedicated spotlight. The focus on plant-based therapies signaled their growing role in healthcare — once fringe, now central to Europe’s pharmaceutical conversation.
Global Lessons, Local Opportunities: How Patient-Centered Reform Can Shape Cannabis Markets
Leaders including Sasho Stefanoski and Jamie L. Pearson joined the Medical Resource Association, Inc. panel, exploring global cannabis lessons, local opportunities, and the need for patient-centered systems built on trust, sustainability, and innovation.
Science in the City International 2025: Cannabis Leaders Gather in Bordeaux
Science in the City International returns to Bordeaux on Sept 11–12, 2025, with global leaders in cannabis science, medicine, and industry. Featuring voices like PHCANN CEO Sasho Stefanoski, the summit blends education, networking, and French elegance at La Cité du Vin.
enua CEO Albert Schwarzmeier on Building a European Powerhouse in Medical Cannabis
Enua CEO Albert Schwarzmeier has scaled the German company from 15 to 55 employees and built strong pharmacy partnerships, making it a top-three medical cannabis distributor. With expansion into the UK and Poland ahead, enua is shaping Europe’s fast-growing €2B cannabis market.
Subscribe to new posts.
Subscribe to be notified of new content and support Honeysuckle Magazine, help keep this site independent.
